Menu
Recruiting NCT06127121

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

Observational Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Digital Art Activity.
Who it may be relevant to
Registry conditions: Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.

Detailed description

Primary objective:

* To evaluate how engaging in a digital art activity might potentially cause changes in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom Assessment System (ESAS) at time T3.

Secondary objectives:

* To evaluate the changes in symptom reporting, based on pre/post self-reporting on ESAS at different times of the study (T1, T2). * To evaluate how a specific creative art making activity (T3), compared to an active control condition (T2; music listening) may or may not impact reporting ESAS. * To monitor potential changes in distress disclosure, based on the self-report scoring on the Distress Disclosure Index score at T0, T2 and T3.

Interventions

  • Behavioral Digital Art Activity
    * complete a symptom questionnaire * complete another activity such as listening to meditative music for 10 minutes * fill out the symptom questionnaire and engage in the digital art activity again

Primary outcome measures

  • The Edmonton Symptom Assessment System, (ESAS) questionnaires [Time frame: through study completion; an average 1 year.]

Eligibility criteria

Inclusion criteria

  • Age equal or greater than 18 years
  • Patients who are admitted in the hospital and have received a cancer diagnosis.
  • Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer.
  • Voluntary written consent.
  • Fluent in English or Spanish.

Exclusion criteria

  • Not being able to use a digital tablet
  • Being speech impaired or vision impaired
  • Patients who are cognitively impaired and unable to read or consent for the study
  • Pregnant women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • MD Anderson Cancer Center — Houston

Identifiers

NCT: NCT06127121 · 2023-0328 · NCI-2023-09557

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗